Science Applications International (SAIC) EPS Estimated At $1.02; 8 Analysts Are Bullish Recro Pharma (REPH) Last Week

May 19, 2017 - By Vivian Park

Analysts expect Science Applications International Corp (NYSE:SAIC) to report $1.02 EPS on June, 12.They anticipate $0.22 EPS change or 27.50% from last quarter’s $0.8 EPS. SAIC’s profit would be $42.85M giving it 17.68 P/E if the $1.02 EPS is correct. After having $0.79 EPS previously, Science Applications International Corp’s analysts see 29.11% EPS growth. The stock increased 0.82% or $0.59 during the last trading session, reaching $72.13. About shares traded. Science Applications International Corp (NYSE:SAIC) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.

Among 8 analysts covering Recro Pharma (NASDAQ:REPH), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Recro Pharma had 10 analyst reports since August 25, 2015 according to SRatingsIntel. The rating was initiated by Roth Capital on Friday, September 16 with “Buy”. H.C. Wainwright initiated the stock with “Buy” rating in Tuesday, November 24 report. The stock has “Buy” rating by Brean Capital on Monday, October 3. The firm has “Buy” rating given on Monday, August 29 by Janney Capital. The firm earned “Buy” rating on Monday, November 14 by Aegis Capital. The rating was initiated by H.C. Wainwright on Wednesday, September 2 with “Buy”. Piper Jaffray initiated it with “Overweight” rating and $12 target in Monday, December 19 report. The stock has “Buy” rating by TH Capital on Friday, September 16. As per Tuesday, August 25, the company rating was upgraded by Zacks. See Recro Pharma Inc (NASDAQ:REPH) latest ratings:

19/12/2016 Broker: PiperJaffray Rating: Overweight New Target: $12.00 Initiates Coverage On
19/12/2016 Broker: Piper Jaffray Rating: Overweight New Target: $12 Initiate

Since December 17, 2016, it had 0 insider buys, and 6 sales for $4.71 million activity. KEENE NAZZIC S also sold $1.85M worth of Science Applications International Corp (NYSE:SAIC) on Tuesday, February 14. SANDERSON EDWARD J JR sold $304,611 worth of stock. WAGONER DOUGLAS MARTIN had sold 7,354 shares worth $631,842 on Saturday, December 17.

Among 9 analysts covering Science Applications International (NYSE:SAIC), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. Science Applications International had 17 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, January 20 by Jefferies. The firm has “Hold” rating given on Friday, September 9 by Drexel Hamilton. BB&T Capital initiated the shares of SAIC in report on Tuesday, July 28 with “Buy” rating. On Wednesday, September 2 the stock rating was upgraded by Citigroup to “Buy”. Citigroup maintained the stock with “Buy” rating in Tuesday, June 14 report. The firm earned “Buy” rating on Thursday, February 16 by Seaport Global Securities. The stock has “Buy” rating by SunTrust on Thursday, December 10. The firm earned “Neutral” rating on Tuesday, November 29 by Citigroup. Suntrust Robinson initiated Science Applications International Corp (NYSE:SAIC) rating on Thursday, December 10. Suntrust Robinson has “Buy” rating and $58 target. The firm has “Buy” rating given on Wednesday, June 8 by Citigroup.

Investors sentiment decreased to 1.43 in 2016 Q4. Its down 0.03, from 1.46 in 2016Q3. It worsened, as 23 investors sold Science Applications International Corp shares while 77 reduced holdings. 53 funds opened positions while 90 raised stakes. 28.52 million shares or 4.97% more from 27.17 million shares in 2016Q3 were reported. Tiaa Cref Inv Lc accumulated 180,530 shares. California State Teachers Retirement System accumulated 0.02% or 87,335 shares. Shell Asset Mngmt, a Netherlands-based fund reported 16,044 shares. Virginia Retirement Et Al holds 0.01% of its portfolio in Science Applications International Corp (NYSE:SAIC) for 6,100 shares. Royal Bancshares Of Canada reported 5,560 shares or 0% of all its holdings. Eqis Mngmt invested 0.03% of its portfolio in Science Applications International Corp (NYSE:SAIC). Ny State Common Retirement Fund holds 75,337 shares or 0.01% of its portfolio. New York Life owns 869 shares for 0.35% of their portfolio. The United Kingdom-based Hsbc Holdg Public Limited Company has invested 0% in Science Applications International Corp (NYSE:SAIC). Mayo Investment Advisers Ltd Liability Corp holds 0.4% in Science Applications International Corp (NYSE:SAIC) or 22,500 shares. Keybank National Association Oh invested in 10,858 shares or 0.01% of the stock. Moreover, Ami Asset Mngmt has 0.34% invested in Science Applications International Corp (NYSE:SAIC). Voloridge Mngmt Ltd Liability invested in 0.1% or 56,463 shares. One Trading L P reported 100 shares. Guardian Tru Communications owns 55 shares or 0% of their US portfolio.

Science Applications International Corporation is a well-known provider of technical, engineering and enterprise information technology (IT) services. The company has market cap of $3.03 billion. The Firm provides its services primarily to the United States Government, including the Department of Defense (DoD), the intelligence community and federal civilian agencies. It has a 22.37 P/E ratio. The Firm provides engineering, systems integration and information technology offerings for government projects, and offers a range of services with a targeted emphasis on higher-end, differentiated technology services.

The stock increased 0.48% or $0.04 on May 18, reaching $8.39. About shares traded. Recro Pharma Inc (NASDAQ:REPH) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.

Since December 13, 2016, it had 4 buys, and 11 selling transactions for $4.15 million activity. Stonepine Capital Management – LLC sold 244,629 shares worth $1.87 million. On Tuesday, March 14 SCP Vitalife Partners (Israel) II – L.P. sold $120,243 worth of Recro Pharma Inc (NASDAQ:REPH) or 15,023 shares. 800 shares were bought by Flynn Karen, worth $5,364. SCP Vitalife Partners II LP also sold $63,261 worth of Recro Pharma Inc (NASDAQ:REPH) on Monday, February 13. Weisman Wayne had bought 7,000 shares worth $45,830 on Thursday, December 15. ALTOMARI ALFRED also bought $9,825 worth of Recro Pharma Inc (NASDAQ:REPH) on Thursday, December 15. $3.90M worth of Recro Pharma Inc (NASDAQ:REPH) was bought by Broadfin Healthcare Master Fund Ltd on Tuesday, December 13.

Recro Pharma, Inc. is a clinical-stage specialty pharmaceutical company. The company has market cap of $157.39 million. The Firm is engaged in developing products for hospitals and ambulatory care settings that is developing non-opioid products for treatment of serious acute pain. It currently has negative earnings. The Company’s lead product candidate is an injectable form of meloxicam.

Investors sentiment increased to 2.73 in 2016 Q4. Its up 0.51, from 2.22 in 2016Q3. It is positive, as 6 investors sold Recro Pharma Inc shares while 5 reduced holdings. 17 funds opened positions while 13 raised stakes. 9.51 million shares or 83.70% more from 5.18 million shares in 2016Q3 were reported. Blackrock Investment Mgmt Limited Co holds 1,311 shares or 0% of its portfolio. Kingdon Capital Mgmt Limited Company holds 0.12% or 311,072 shares. Moreover, Northern has 0% invested in Recro Pharma Inc (NASDAQ:REPH) for 16,213 shares. Moreover, Creative Planning has 0% invested in Recro Pharma Inc (NASDAQ:REPH) for 500 shares. Deerfield Mngmt has 0.69% invested in Recro Pharma Inc (NASDAQ:REPH). Steelhead Prtn Limited Liability stated it has 4,000 shares. Cormorant Asset Mngmt Ltd reported 0.66% of its portfolio in Recro Pharma Inc (NASDAQ:REPH). Blackrock Advsrs Limited Liability Company reported 2,418 shares. Bb&T Corp holds 0.01% of its portfolio in Recro Pharma Inc (NASDAQ:REPH) for 50,000 shares. Barclays Public Ltd Com stated it has 2,278 shares. The Pennsylvania-based Janney Montgomery Scott Ltd Liability Corp has invested 0% in Recro Pharma Inc (NASDAQ:REPH). Segantii Mgmt Ltd owns 3,800 shares. Prelude Capital Mgmt Lc, a New York-based fund reported 20,879 shares. Tower Research Ltd Co (Trc) reported 500 shares stake. Dimensional Fund Advisors L P invested in 0% or 14,600 shares.